Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study-Reference-Cited by-同舟云学术

Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study

Published:2016-11 Issue:10 Volume:24 Page:679-687
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Pérez Teresa,Makrestsov Nikita,Garatt John,Torlakovic Emina,Gilks C. Blake,Mallett Susan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference16 articles.

1. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version);Hammond;Arch Pathol Lab Med,2010

2. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance;Barnes;Eur J Cancer,1998

3. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries;Rhodes;J Clin Pathol,2000

4. Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests;Torlakovic;Am J Clin Pathol,2010

5. Protocol for the examination of specimens from patients with invasive carcinoma of the breast;Lester;Arch Pathol Lab Med,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center;The Breast;2024-06

2. Assessing the impact of the phase-out measures during COVID-19 pandemic, using regression models: a longitudinal observational study;BMJ Open;2022-11

3. Lost but Not Least—Novel Insights into Progesterone Receptor Loss in Estrogen Receptor-Positive Breast Cancer;Cancers;2021-09-23

4. Biomarker testing in oncology – Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL;Virchows Archiv;2020-10-13

5. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update;Journal of Clinical Oncology;2020-04-20